Oxandrolone 50 - Genetic Pharmaceuticals

The history of Oxandrolone began not in performance athletics but in hospitals, where G.D. Searle & Co. introduced it in 1962 as a medical steroid for treating wasting syndromes and delayed growth. It was released under the name Anavar and used worldwide. Over time, however, its adoption in sports drew criticism, and Searle halted production in 1989. By 1995, Bio-Technology General Corp. had revived the compound as Oxandrin. With orphan drug status, it was now used to support weight gain in severely ill patients under tightly regulated clinical protocols

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Oxandrolone 50 by Genetic Pharmaceuticals, consult with your doctor or healthcare professional.